Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Pharmather Holdings Ltd PHRRF


Primary Symbol: C.PHRM

PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The... see more

CSE:PHRM - Post Discussion

Pharmather Holdings Ltd > High Impact...multi-bagger!!!!
View:
Post by TheLandedEagles on Apr 27, 2024 9:10pm

High Impact...multi-bagger!!!!

Investors looking for Big Rewards with minimal risk at this late stage of a FDA imminent approval,...needs to have a locked-in share position in PharmaTher....Hugh upside very soon.
Look to the company's latest February 2024 Presentation on their web-site. Hold and Accumulate, at these extremely low prices....All time high was $1.20/share in 2021, raised $10mm in August 2021 at .66 cents/share with warrants expiring in 2026 at .80 cents exercise price, and that will bring in more than $6mm in cash and adding in their current $4mm cash, gives them a total of $10mm to finance its marketing/Sales and distribution for its approved FDA KETRAX....NO NEED FOR ANY FINANCING!!! Preventing share dilution....great financial position ...
Comment by Itistoo on Apr 29, 2024 12:56am
They are actually closer to 2 mil in the bank right now, so they really need to get this approval sooner than later.  Just as important as that they need to have clients and sales lined up. If they can line those ducks up and get a nice bump in SP to execute warrants, that would be ideal.  If not, cash burn will get to them and they will have to do a raise.
Comment by TheLandedEagles on May 04, 2024 1:27pm
Sorry my error...warrants are showing to be 16.8mm out at a exercise price of .80 cents...this could bring in potential cash funds of $13.4mm...NOT the $6mm indicated. See web "presentation"..This company with FDA approval and stock moves much higher, may trigger the warrants and then company is self-funded for its commerialization..Prefect scenario ..and having a very low shares ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities